000 | 01566 a2200397 4500 | ||
---|---|---|---|
005 | 20250513101739.0 | ||
264 | 0 | _c19970108 | |
008 | 199701s 0 0 eng d | ||
022 | _a1064-1963 | ||
024 | 7 |
_a10.3109/10641969609081780 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBell, D R | |
245 | 0 | 0 |
_aSelective effect of high arterial pressure in hypertension upon inhibition of cGMP versus cAMP mediated vascular relaxation. _h[electronic resource] |
260 |
_bClinical and experimental hypertension (New York, N.Y. : 1993) _cAug 1996 |
||
300 |
_a773-91 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta, Abdominal _xdrug effects |
650 | 0 | 4 |
_aAorta, Thoracic _xdrug effects |
650 | 0 | 4 |
_aBlood Pressure _xphysiology |
650 | 0 | 4 |
_aBucladesine _xpharmacology |
650 | 0 | 4 |
_aCyclic AMP _xphysiology |
650 | 0 | 4 |
_aCyclic GMP _xanalogs & derivatives |
650 | 0 | 4 |
_aHypertension, Renovascular _xphysiopathology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aIsoproterenol _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide _xpharmacology |
650 | 0 | 4 |
_aNitroglycerin _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aVasodilation _xdrug effects |
700 | 1 | _aDec, E M | |
700 | 1 | _aRensberger, H J | |
773 | 0 |
_tClinical and experimental hypertension (New York, N.Y. : 1993) _gvol. 18 _gno. 6 _gp. 773-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/10641969609081780 _zAvailable from publisher's website |
999 |
_c8836748 _d8836748 |